Economic evaluation and society's health values: View from the other side of the pondBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7486.311-a (Published 03 February 2005) Cite this as: BMJ 2005;330:311
- Rhiannon Tudor Edwards, Harkness fellow in health care policy 2004/5 ()
- MacColl Institute for Healthcare Innovation, Center for Health Studies, Group Health Cooperative, 1730 Minor Avenue, Seattle, WA 98101, USA
Americans fiercely defend their right to choose their doctor, value competition as a stimulant to medical advance, and are not ready to extend healthcare coverage to all Americans. Health economists in the United States have not focused in the same way as UK health economists on cost effectiveness analysis, since in a market based system, less emphasis is placed on the value for money of health care, and more on meeting consumers' demands. They have focused instead on measuring costs and productivity,3 on forecasting spiralling Medicare costs, and on the costs of malpractice litigation.4
In the United States, most, but not all, health economists adhere to the arguments in favour of market competition, reflecting deeply held US societal values that, like washing machines, health care can be most efficiently produced and consumer choice maximised through competition. Health economists in the United Kingdom have striven to develop methods of economic evaluation as a means to support policy makers. These policy makers face prioritisation decisions about what a universal, tax funded healthcare system, free at the point of access, can and cannot afford to provide.
In not stating her wholly UK perspective, Coast fails to convey that the development of methods of economic evaluation by UK health economists does in fact reflect deep seated UK societal values and commitment to socialised medicine.5
Conflict of interests None declared